Sampled documentary spotlights sample handling behind research breakthroughs
A new CNBC.com documentary featuring Sampled examines how biological samples are protected, tracked and analyzed to support research and drug development. The piece highlights why sample integrity and advanced lab infrastructure matter as studies grow more complex and data needs become more demanding.
Why it matters: - Biological samples are the starting point for many medical breakthroughs, from therapies and diagnostics to biomarkers and new technologies. - Sample integrity, traceability, continuity and accessibility directly affect the quality and reliability of research data. - As sample collections grow across sites and time points, the systems around storage and analysis can determine whether valuable materials remain useful for future science.
What happened: - A new documentary featuring Sampled is now available on CNBC.com as part of the Global Thought Leaders series. - The documentary focuses on how biological samples drive research, drug discovery and development. - The full documentary is available through Acumen’s Global Thought Leaders series at the Sampled documentary.
The details: - Sampled CEO John DelliSanti said the samples are “irreplaceable connections” to donors and to research that may lead to better treatments and outcomes. - Sampled works with foundations, nonprofits, pharmaceutical and biotechnology companies, academic institutions and research organizations. - Biological samples may move from collection to processing, laboratory analysis and long-term storage across multiple providers. - Each transfer, temperature change, freeze-thaw cycle or added handling step can increase risk and affect the reliability of resulting data. - Sampled’s Piscataway, New Jersey facility combines a large-scale biorepository with sample processing and advanced laboratory capabilities. - Those capabilities include next-generation sequencing, single-cell and spatial technologies, proteomics and bioinformatics. - Housing storage, processing and analytics in one location can reduce handoffs and transfer-related risk. - Standardized workflows and operating procedures are part of the effort to support more consistent and reliable data. - Properly preserved and well-characterized samples can be revisited as new technologies and research questions emerge.
Between the lines: - The documentary positions sample logistics as a core part of modern life sciences, not a back-office function. - As research tools become more powerful, older samples can gain new value when they are stored and documented well enough to be reanalyzed later. - The company is tying its infrastructure story to a broader argument about how operational rigor can speed scientific progress.
What's next: - Researchers are likely to keep leaning on long-term sample storage and multi-omics analysis as studies become larger and more complex. - Sampled’s messaging suggests continued focus on integrating storage, processing and analysis in one workflow. - More information is available on Sampled’s LinkedIn page.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Today in Science
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.